Product Information
NMO-IgG Blocker A-01 is a recombinant protein that blocks the binding of the autoantibodies NMO-IgG in patients with neuromyelitis optica. The antibody binds to NMDA receptor and inhibits its function. This drug has been shown to be effective for the treatment of NMO, improving clinical symptoms such as visual loss and muscle weakness.
Chemical properties
Technical inquiry about: 3D-BPA52271 NMO-IgG Blocker A-01
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.